Browse > Article
http://dx.doi.org/10.15204/jkobgy.2020.33.3.020

A Review of the Domestic Study Trends on Premature Ovarian Failure Treated with Korean Medicine  

Kim, Min-Kyung (Dept. of Korean Obstetrics & Gynecology, Daejeon Jaseng Hospital of Korean Medicine)
Kim, Suna (Dept. of Korean Obstetrics & Gynecology, Daejeon Jaseng Hospital of Korean Medicine)
Kim, Su-Jin (Dept. of Korean Obstetrics & Gynecology, Daejeon Jaseng Hospital of Korean Medicine)
Jeong, Wu-Jin (Dept. of Acupuncture & Moxibustion, Daejeon Jaseng Hospital of Korean Medicine)
Huh, Hyo-Seung (Dept. of Acupuncture & Moxibustion, Daejeon Jaseng Hospital of Korean Medicine)
Kim, Hye-Gyeong (Dept. of Korean Medicine Ophthalmology & Otolaryngology & Dermatology, Daejeon Jaseng Hospital of Korean Medicine)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.33, no.3, 2020 , pp. 20-39 More about this Journal
Abstract
Objectives: This study was performed to examine the domestic study trends on premature ovarian failure (POF) treated with Korean medicine. Methods: We investigated the studies on Korean medicine treatment for premature ovarian failure via searching 4 online databases. Results: 13 clinical studies were selected. All studies were the noncomparative studies, and mainly case reports. Studies were publicated from 2001 to 2019 and the number of studies with 1 subject was the greatest (76.9%). In accompanying symptoms, there was a study which did not report entire cases. In the 11 case reports (13 subjects), the most accompanying symptoms was hot flush (69.2%). In treatment of premature ovarian failure, the most used treatment was herbal medicine, which was used in all studies. Acupuncture treatment was used in 6 studies (46.2%) and moxibustion treatment was used in 8 studies (61.5%). The most common acupuncture point was 內關 (SP6) in acupuncture treatment, and was 關元 (CV4) in moxibustion treatment. The duration of treatment was between 1 month and 20 months, the average 7.76 months. Used outcome measurements were hormone test (84.6%), menstruation (76.9%), Visual analog sclale (VAS) (15.4%), ultrasonography (15.4%), Numeral rating scale (NRS), Body basal temperature (BBT) and Kupperman index (7.7%). In total 70 subjects, 13 subjects (18.6%) became pregnancy and 25 subjects (35.7%) had no effect. Follow up was reported in 6 studies, and the average duration of follow up was 141.63 days. Conclusions: Further clinical trials are needed to establish the evidence for Korean Medicine treatment for premature ovarian failure.
Keywords
Premature Ovarian Failure; Korean Medicine; Herbal Medicine; Acupuncture;
Citations & Related Records
Times Cited By KSCI : 9  (Citation Analysis)
연도 인용수 순위
1 Korean Society of Obstetrics &Gynecology. Gynecology. 4th ed. Seoul:Korea Medical Book Publisher co. 2008:563, 970.
2 Davis SR. Premature ovarian failure. Maturitas. 1996;23(1):1-8.   DOI
3 Huh JS, et al. Retrospective Multicenter Study on Clinical Aspects in Premature Ovarian Failure. J Korean Menopause. 2011;17(13):160-5.   DOI
4 Cust MP. Changes in practice since the publication in 2007 of further results from the Women's Health Initiative and the Million Women Study. Menopause International. 2007;13(4):141-3.   DOI
5 Jang GB. Gyeongagjeonseo.1st rev. ed. Seoul:Hanmi. 2006:1754-7.
6 Hwangbo SM, et al. A Clinical Study on 1 Case of Pregnancy in Ovulation Disorder Patient Resistant to Controlled Ovarian Hyperstimulation. J Korean Obstet Gynecol. 2018;31(3):121-30.   DOI
7 Korean Oriental Society of Obstetrics and Gynecology. 3rd rev. ed. Oriental Obstetrics and Gynecology. vol. 3. Seoul: Euiseongdang. 2016:19-21, 174, 230.
8 Choi SJ, Kim DI. A Case Report of Primaacry Ovarian Insufficiency Treated with Korean Medicine Treatment. J Korean Obstet Gynecol. 2019;32(4):170-80.
9 Baek JS. A Clinical Study on One Case of a Spontaneous Pregnancy with Premature Ovarian Failure. J Korean Obstet Gynecol. 2018;31(2):95-102.   DOI
10 Kang SJ, et al. A Clinical Study on 1 Case of Secondary Amenorrhea after Ovarian Surgery for Bilateral Endometriomas Diagnosed as Premature Ovarian Failure. J Korean Obstet Gynecol. 2018;31(2):113-22.   DOI
11 Koh JE, Lyou MS. Two Cases of Oriental Medicine on Premature Ovarian Failure by Checking Ultrasonography and Serum Hormone Assay. J Korean Obstet Gynecol. 2016;29(1):116-26.   DOI
12 Jang SB, et al. A Clinical Study on 1 Case of Infertility Patient with Premature Ovarian Failure. J Korean Obstet Gynecol. 2014;27(3):135-42.   DOI
13 Kim HJ, et al. Clinical Study for the One Case of Premature Ovarian Failure by Serum Hormone Assay. J Korean Obstet Gynecol. 2011;24(2):134-41.   DOI
14 Choi EM, et al. A Clinical Study on Infertility with Premature Ovarian Failure. J Korean Obstet Gynecol. 2001;14(1):393-408.
15 Lee YK, et al. A Case Report of Climacteric Symptoms in Premature Ovarian Failure Patient Who Has One Side Ovariectomy and Pelvic Tuberculosis. J Korean Obstet Gynecol. 2008;21(3):269-78.
16 Cho HJ, et al. Premature Ovarian Failure 28 Case Series. J Korean Obstet Gynecol. 2004;17(4):149-57.
17 Cho HJ, Choi EM, Kang MJ. Pregnancy in Premature Ovarian Failure after Oriental Medicine Treatment. Two Cases Report. J Korean Obstet Gynecol. 2004;17(2):200-8.
18 Kim SH, et al. A case report of managing the premature ovarian failure patient. J Korean Obstet Gynecol. 2003;16(3):194-9.
19 Ko YM, Zhang KH, Kim SW. A Case of Recovery of Ovarian Function in Woman Who was diagnosed as Premature Ovarian Failure. J Korean Obstet Gynecol. 2002;15(4):193-201.
20 Taylor AE, et al. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab. 1996;81(10):3615-21.   DOI
21 Kalantaridou SN, et al. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement. Trends in Endocrinology & Metabolism. 2006;17(3):101-9.   DOI
22 Rebar RW. Connoly HV. Clinical features of young woman with hypergonadotropic amenorrhea. Fertil Steril. 1990;53(5):804-10.   DOI
23 Van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5(5):483-92.   DOI
24 La Marca A, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113-30.   DOI
25 Korean Acupuncture & Moxibustion Medicine Society. 1st rev. ed. The Acupuncture and Moxibustion. Gyeonggido: Jipmoondang. 2012:785-811.
26 Visser JA, et al. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1-9.   DOI